From epidemiology to pathophysiology: what about caffeine in Alzheimer's disease?

Biochemical Society transactions2014Flaten V, Laurent C, Coelho JE, et al.

Study designReview

SubjectHuman & animal

Abstract

cc by 以外（cc by-nc / cc by-nc-nd / NONE 等）は抄録を再掲しない。DOI/PMID へのリンクのみ表示する。

Alzheimer DiseaseAnimalsCaffeineHumansPurinergic P1 Receptor AntagonistsReceptors, Purinergic P1

DOI 10.1042/bst20130229

PMID 24646282